Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.
Howard C HerrmannRoxana MehranDaniel J BlackmanStephen BaileyHelge MöllmannMohamed Abdel-WahabWalid Ben AliPaul D MahoneyHendrik RugeDavid A WoodSabine BleizifferBasel RamlawiHemal GadaAnna Sonia PetronioCharles D ResorWilliam MerhiBruno Garcia Del BlancoGuilherme F AttizzaniWayne B BatchelorLinda D GillamMayra GuerreroToby RogersJoshua D RovinMolly SzerlipBrian WhisenantG Michael DeebKendra J GrubbRatnasari PadangMyra T FanAndrew D AlthouseDidier Tchétchénull nullPublished in: The New England journal of medicine (2024)
Among patients with severe aortic stenosis and a small aortic annulus who underwent TAVR, a self-expanding supraannular valve was noninferior to a balloon-expandable valve with respect to clinical outcomes and was superior with respect to bioprosthetic-valve dysfunction through 12 months. (Funded by Medtronic; SMART ClinicalTrials.gov number, NCT04722250.).